Top

Critical Care

Published in:

Open Access 01-12-2020 | Acute Respiratory Distress-Syndrome | Research Letter

Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients

Authors: Aijia Ma, Jiangli Cheng, Jing Yang, Meiling Dong, Xuelian Liao, Yan Kang

Published in: Critical Care | Issue 1/2020

Trial registration

ChiCTR, ChiCTR2000029758. Registered 12 February 2020 - Retrospectively registered

Liew MF, Siow WT, MacLaren G, See KC. Preparing for COVID-19: early experience from an intensive care unit in Singapore. Crit care (London). 2020;24(1):83.CrossRef

Ramanathan K, Antognini D, Combes A, Paden M, et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med. 2020;8(5):518–26.CrossRef

Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;S0163-4453(20)30208-5. https://doi.org/10.1016/j.jinf.2020.04.002.

Liao X, Chen H, Wang B, Li Z, et al. Critical care for patients with severe COVID-2019 in Sichuan Province, China——a provincial cohort study.medRxiv 2020.03.22.20041277; https://doi.org/10.1101/2020.03.22.20041277.

Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin definition. Jama. 2012;307(23):2526–33.

Gattinoni L, Coppola S, Cressoni M, et al. COVID-19 Does Not Lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;201(10):1299–300. https://doi.org/10.1164/rccm.202003-0817LE.

Title: Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients
Authors: Aijia Ma
Jiangli Cheng
Jing Yang
Meiling Dong
Xuelian Liao
Yan Kang
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Acute Respiratory Distress-Syndrome
COVID-19
ECMO
ECMO
Biomarkers
Published in: Critical Care / Issue 1/2020
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/s13054-020-03007-0

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients

Trial registration

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2020

Is previous influenza-like illness a potential Trojan horse for COVID-19?

Description of an alternative method for optimal and comfortable two-handed face mask ventilation: the transverse mandibular technique

Association between incident delirium and 28- and 90-day mortality in critically ill adults: a secondary analysis

Naloxone should remain the appropriate antidote to treat opioid overdose

A systematic review of biomarkers multivariately associated with acute respiratory distress syndrome development and mortality

The importance of a “socially responsible” approach during COVID-19: the invisible heroes of science in Italy